Raised antibody levels linked to greater long term risk of rheumatoid arthritis
Men and women with raised levels of an antibody known as rheumatoid factor in their blood have up to a 26-fold greater long term risk of developing rheumatoid arthritis, finds a study published in the British Medical Journal today. ...
Arthritis & Rheumatism
Sep 06, 2012 |
not rated yet |
0
Simple blood tests detect autoimmune kidney disease, help predict prognosis
Simple blood tests could help physicians decide which patients with a particular autoimmune kidney disease can forgo potentially toxic medications and which need to be treated, according to a study appearing in an upcoming ...
Diseases, Conditions, Syndromes
Sep 06, 2012 |
not rated yet |
0
Some patients with common kidney disease can skip standard treatments
For patients with a common kidney disease who have normal kidney function and only minor urinary abnormalities at the time of diagnosis, the long-term prognosis is excellent and no special treatments are needed, according ...
Diseases, Conditions, Syndromes
Sep 06, 2012 |
not rated yet |
0
Adding bavituximab to second-line chemotherapy doubles response rate
Adding the monoclonal antibody bavituximab to docetaxel chemotherapy doubles overall response rate and improves progression-free survival and overall survival in late-stage non-squamous, non-small cell lung cancer (NS-NSCLC) ...
Cancer
Sep 06, 2012 |
5 / 5 (2) |
0
Antibody prevents hepatitis C in animal model
A monoclonal antibody developed by MassBiologics of the University of Massachusetts Medical School (UMMS) and tested in an animal model at the Texas Biomedical Research Institute, prevents infection by the hepatitis C virus ...
Diseases, Conditions, Syndromes
Aug 30, 2012 |
5 / 5 (1) |
0
|
Cetuximab, paclitaxel combo active in urothelial cancer
(HealthDay)—The monoclonal antibody against epidermal growth factor receptor (EGFR), cetuximab, augments the antitumor activity of paclitaxel in patients with previously treated urothelial cancer, according ...
Cancer
Aug 29, 2012 |
not rated yet |
0
Knowing origin of broadly neutralizing antibodies could aid universal flu vaccine design
National Institutes of Health scientists have identified how a kind of immature immune cell responds to a part of influenza virus and have traced the path those cells take to generate antibodies that can neutralize a wide ...
Medical research
Aug 29, 2012 |
not rated yet |
0
|
Belimumab for lupus erythematosus: Added benefit not proven
Belimumab (trade name Benlysta) has been approved since July 2011 as an add-on therapy for adult patients with the autoimmune disease systemic lupus erythematosus (SLE). This monoclonal antibody is only considered as treatment ...
Cancer
Aug 29, 2012 |
not rated yet |
0
New hope for spinal cord injury patients
A new antibody could reverse the damage caused by trauma to the central nervous system, according to new research.
Diseases, Conditions, Syndromes
Aug 29, 2012 |
3 / 5 (1) |
0
Double attack on SARS
After the SARS-CoV (severe acute respiratory syndrome coronavirus) outbreak in 2003, academia experts in immunology and molecular biology joined forces with industrial vaccine production experts in order ...
Diseases, Conditions, Syndromes
Aug 28, 2012 |
not rated yet |
0
Targeting sugars in the quest for a vaccine against HIV -- the virus that causes AIDS
As a step toward designing the first effective vaccine against HIV, the virus that causes AIDS, scientists are reporting new insights into how a family of rare, highly potent antibodies bind to HIV and neutralize it — ...
HIV & AIDS
Aug 21, 2012 |
not rated yet |
0
Dual action polyclonal antibody may offer more effective, safer protection against osteoporosis
A new study suggests that a polyclonal antibody that blocks follicle-stimulating hormone (FSH) in mice without ovaries might offer a more effective way to prevent or arrest osteoporosis than currently available treatments.
Medical research
Aug 20, 2012 |
5 / 5 (1) |
0
|
Mepolizumab almost halves exacerbations in patients with severe asthma
The largest study of patients with severe asthma to date, published in the Lancet special issue on respiratory medicine, shows that those treated with the monoclonal antibody mepolizumab experienced an almost 50 percent reduct ...
Immunology
Aug 16, 2012 |
not rated yet |
0
Blood markers reveal severity of common kidney disease
Increasing blood levels of particular proteins may act as warning signs for patients with one of the most common diseases of the kidney, according to a study appearing in an upcoming issue of the Journal of the American So ...
Diseases, Conditions, Syndromes
Aug 16, 2012 |
not rated yet |
0
Study suggests potential hurdle to universal flu vaccine development may be overcome
In the quest for a universal influenza vaccine—one that elicits broadly neutralizing antibodies that can protect against most or all strains of flu virus—scientists have faced a sobering question: Does pre-existing ...
Diseases, Conditions, Syndromes
Aug 15, 2012 |
not rated yet |
0
|
